Testing effectiveness (Phase 2)Study completedNCT00074074
What this trial is testing
Infliximab in Treating Patients With Myelodysplastic Syndrome
Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 46